Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Bimatoprost Ocular Insert
NCT02444767Phase 1Completed
- Sponsor
- ForSight VISION5
- Start
- Mar 2015
- Primary completion
- Apr 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bimatoprost in open-angle glaucoma (OAG) and ocular hypertension, sponsored by ForSight VISION5. Primary endpoint: Whole blood concentrations of bimatoprost and bimatoprost acid at 7 days. Started Mar 2015; status: completed.
02
Drugs
bimatoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT02444767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444767.